Tag Archives: Covid-19 Podcasts

Covid-19 Podcast: What Are Vaccine Side Effects?

From a sore arm to anaphylaxis, a wide range of adverse events have been reported after people have received a COVID-19 vaccine. And yet it is unclear how many of these events are actually caused by the vaccine. In the vast majority of cases, reactions are mild and can be explained by the body’s own immune response.

But monitoring systems designed to track adverse events are catching much rarer but more serious events. Now scientists need to work out if they are causally liked to the vaccine, or are just statistical anomalies – and that is not an easy task.News: Why is it so hard to investigate the rare side effects of COVID vaccines?Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Covid-19: Walgreens To Offer At-Home Saliva Tests

Clinical Reference Laboratory CEO Bob Thompson talks about Walgreens offering a Covid-19 at-home saliva test. 

Bloomberg News Equity Markets Reporter Esha Dey discusses Tesla falling below its S&P 500 entry level and wiping out 2021 gains. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Chief Energy Correspondent Javier Blas walk through the story “Pennsylvania Teachers’ Pensions Helped Fund War Over Oil in Iraq.” Dartmouth Professor of Economics Danny Blanchflower provides a recap of Fed Chair Jerome Powell’s semi-annual monetary policy report to the Senate Banking Committee. And we Drive to the Close with Ryan Detrick, Senior Market Strategist at LPL Financial. Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway.

Covid-19: Understanding The New Variants & New Vaccines Effectiveness

Researchers are scrambling to understand the biology of new coronavirus variants and the impact they might have on vaccine efficacy.

Around the world, concern is growing about the impact that new, faster-spreading variants of the SARS-CoV-2 virus will have on the pandemic.

In this episode of Coronapod, we discuss what these variants are, and the best way to respond to them, in the face of increasing evidence that some can evade the immunity produced by vaccination or previous infection.

News: ‘A bloody mess’: Confusion reigns over naming of new COVID variants

News: Fast-spreading COVID variant can elude immune responses

News: Could new COVID variants undermine vaccines? Labs scramble to find out

News: How to redesign COVID vaccines so they protect against variants

News: J&J’s one-shot COVID vaccine offers hope for faster protection

Covid-19 Variants: ‘What You Need To Know’ (Video)

Covid-19: ‘The Rise Of The RNA Vaccines’ (Podcast)

Benjamin Thompson, Noah Baker and Elie Dolgin discuss RNA vaccines.

In this episode:

01:16 How RNA vaccines came to prominence

In less than a year, two RNA vaccines against COVID-19 were designed, tested and rolled out across the world. We discuss these vaccines’ pros and cons, how RNA technology lends itself to rapid vaccine development, and what this means for the fight against other diseases.

News feature: How COVID unlocked the power of RNA vaccines

09:20 The hurdles for trialling new COVID-19 vaccines

Multiple candidates for new COVID-19 vaccines are still being developed, which may offer advantages over the vaccines currently available. However, running placebo-controlled trials of these candidates is becoming increasingly difficult, so researchers are looking for different ways to evaluate them.

News: Search for better COVID vaccines confounded by existing rollouts

14:45 How long will COVID vaccines be effective?

There is much concern around the world about two faster-spreading variants of SARS-CoV-2. We get an update on whether these variants could render vaccines ineffective.

News: Could new COVID variants undermine vaccines? Labs scramble to find out

Covid-19: ‘Reducing Risk Now & Preparing For The Next Pandemic’ (Podcast)

Virologist Angela Rasmussen talks about her battle against misinformation in the media, the virus, vaccines, disinfecting surfaces, home testing, and the next pandemic.

Eric J. Topol, MD: Hello, I’m Eric Topol for Medscape, and this is Medicine and the Machine. I’m so glad to have my colleague and partner in this podcast, Abraham Verghese, with me from Stanford. Today, we have the rarefied privilege to discuss the whole pandemic story, the virus and vaccines, with one of the country’s leading virologists, Dr Angela Rasmussen. Welcome, Angie.

Angela L. Rasmussen, MA, MPhil, PhD: Thank you so much for having me, Eric. It’s wonderful to be here.

Covid-19 Podcast: Latest On Vaccine Rollout, New Mutation & FDA Approvals

Stephen Hahn, U.S. Food and Drug Administration Commissioner, Sigal Atzmon, founder and chief executive officer of Medix Global, and Roche CEO Severin Schwan, on the pandemic, Covid-19 vaccines and the new mutation.